MedTrace Logo

Antibiotic Selection Using Next Generation Sequencing vs Urine Culture

NCT04404855 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2024-03-12

Study results available
· View outcomes & findings →

Summary

This is a randomized controlled clinical study evaluating the use of next-generation sequencing (NGS) to improve antibiotic prescribing before ureteroscopy or percutaneous nephrolithotomy.

Conditions

  • Kidney Stone
  • Renal Stone
  • Infection, Bacterial

Interventions

OTHER

NGS + Antibiotic Recommendation

NGS results in addition to recommended antibiotic therapy made by infectious disease pharmacist

PROCEDURE

Standard of Care treatment

Subjects will have a standard of care urine culture and prophylactic antibiotic prescribed per routine care.

Sponsors & Collaborators

  • Microgen LLC

    collaborator INDUSTRY

  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Michael Liss, MD · University of Texas Health at San Antonio

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-18
Primary Completion
2022-01-31
Completion
2022-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04404855 on ClinicalTrials.gov